Address
Email address
Phone number
Website
https://www.pharmasynth.eePharmaSynthPET/SPECT precursors, reference standards and auxiliary reagents in GMP grade.
Name
PharmaSynth AS
Registry code
11044101
VAT number
EE100940196
Type
AS - Joint Stock Company
Status
Registered
Foundation date
29.06.2004 (20)
Financial year
01.01-31.12
Capital
57 180.00 €
Activity
21201 - Manufacture of pharmaceutical preparations
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Heli Väärtnõu-Järv
| 11% - 6 180.00 EUR | - | - | FounderBoard memberShareholder |
| SILLAMATSI MEDICAL OÜ 10913017 | 49% - 28 140.00 EUR | - | - | FounderShareholder |
| Omanikukonto: JUKKA VELI HILTUNEN
| 25% - 14 040.00 EUR | - | - | Shareholder |
| Pirkko-Irene Penttilä-Hiltunen
| - | Board member | - | Founder |
| Olavi Loog
| - | - | - | Board member |
| OÜ EDUSOFT 10769658 | - | - | - | Founder |
| Jukka Veli Hiltunen
| - | - | - | Founder |
| Jaak Järv
| - | - | - | FounderChairman of the board |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 144 888.35 € | 39 878.85 € | 42 231.35 € | 9 |
| 2024 Q3 | 188 774.03 € | 34 015.94 € | 35 984.11 € | 9 |
| 2024 Q2 | 105 108.94 € | 33 097.72 € | 35 257.99 € | 8 |
| 2024 Q1 | 139 706.86 € | 31 247.92 € | 32 989.43 € | 8 |
| 2023 Q4 | 74 760 € | 30 655.78 € | 32 095.88 € | 8 |
| 2023 Q3 | 189 319.51 € | 30 190.54 € | 31 856.61 € | 8 |
| 2023 Q2 | 144 446.36 € | 34 124.62 € | 36 060.7 € | 8 |
| 2023 Q1 | 194 810.66 € | 30 068.21 € | 31 743.36 € | 8 |
| 2022 Q4 | 136 055.56 € | 24 294.54 € | 25 555.64 € | 8 |
| 2022 Q3 | 108 932.07 € | 19 035.63 € | 19 929.45 € | 8 |
| 2022 Q2 | 112 649.3 € | 16 704.07 € | 15 587.78 € | 8 |
| 2022 Q1 | 96 840.74 € | 19 011.71 € | 20 014.68 € | 7 |
| 2021 Q4 | 146 515.77 € | 16 656.35 € | 17 566.97 € | 8 |
| 2021 Q3 | 109 604.25 € | 16 646.19 € | 17 671.99 € | 8 |
| 2021 Q2 | 137 043.77 € | 14 379.25 € | 15 141.82 € | 8 |
| 2021 Q1 | 137 042.39 € | 20 087.77 € | 21 365.31 € | 8 |
| 2020 Q4 | 58 124.73 € | 11 993 € | 12 792.19 € | 8 |
| 2020 Q3 | 82 335 € | 11 905.82 € | 12 671.89 € | 8 |
| 2020 Q2 | 70 810.61 € | 11 233.75 € | 11 943.8 € | 7 |
| 2020 Q1 | 144 400.94 € | 19 608.94 € | 19 640.49 € | 7 |
